Compare Gevo, Inc. with Similar Stocks
Stock DNA
Specialty Chemicals
USD 561 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.14
-7.42%
1.20
Revenue and Profits:
Net Sales:
45 Million
(Quarterly Results - Dec 2025)
Net Profit:
-6 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.61%
0%
4.61%
6 Months
8.61%
0%
8.61%
1 Year
66.91%
0%
66.91%
2 Years
231.92%
0%
231.92%
3 Years
28.98%
0%
28.98%
4 Years
-47.33%
0%
-47.33%
5 Years
-73.23%
0%
-73.23%
Gevo, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
59.03%
EBIT Growth (5y)
-2.41%
EBIT to Interest (avg)
-32.79
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.06
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
41.80%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.20
EV to EBIT
-22.16
EV to EBITDA
-328.44
EV to Capital Employed
1.17
EV to Sales
5.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-5.29%
ROE (Latest)
-7.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 31 Schemes (18.46%)
Foreign Institutions
Held by 56 Foreign Institutions (5.75%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
45.30
42.70
6.09%
Operating Profit (PBDIT) excl Other Income
-0.30
3.80
-107.89%
Interest
4.70
5.20
-9.62%
Exceptional Items
0.10
-0.10
200.00%
Consolidate Net Profit
-6.00
-7.60
21.05%
Operating Profit Margin (Excl OI)
-118.20%
-84.30%
-3.39%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 6.09% vs -1.61% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 21.05% vs -381.48% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
160.60
16.90
850.30%
Operating Profit (PBDIT) excl Other Income
6.50
-67.60
109.62%
Interest
17.60
3.90
351.28%
Exceptional Items
-4.40
-4.90
10.20%
Consolidate Net Profit
-32.60
-78.60
58.52%
Operating Profit Margin (Excl OI)
-117.50%
-5,077.90%
496.04%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 850.30% vs -1.74% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 58.52% vs -18.73% in Dec 2024
About Gevo, Inc. 
Gevo, Inc.
Specialty Chemicals
Gevo Inc. is engaged in commercializing jet fuel, gasoline and diesel fuel. The Company’s fermentation yeast biocatalyst produces isobutanol through fermentation of renewable plant biomass. It operates through two segments: Gevo, Inc. (Gevo) segment and Gevo Development/Agri-Energy segment. Gevo segment is responsible for research and development activities related to the production of isobutanol, including the development of the Company's biocatalysts, the production and sale of renewable jet and other fuels, the Retrofit process and the generation of chemicals and biofuels. The Gevo Development/Agri-Energy segment is responsible for the operation of the Luverne Facility and the production of ethanol, isobutanol and related products. Its products include renewable gasoline, renewable biodiesel, isooctane, sustainable aviation fuel (SAF), isobutylene, ethanol and animal feed.
Company Coordinates 
Company Details
Building C, 345 Inverness Dr S Ste 310 , ENGLEWOOD CO : 80112-5892
Registrar Details






